BioSpace News Archive

ViewRay, Inc. (NASDAQ: VRAY) announced today plans to host an Investor Day on Thursday, November 17, 2022 , at 8:00 a.m. Eastern Time in New York City , NY.

SQZ Biotechnologies Company, focused on unlocking the full potential of cell therapies for multiple therapeutic areas, announced the publication of preclinical research on the SQZ® Activating Antigen Carrier platform.

Eagle Pharmaceuticals, Inc. and Enalare Therapeutics Inc. (“Enalare”) today announced that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation (“ODD”) to ENA-001 for the treatment of Apnea of Prematurity (“AoP”), a new chemical entity with a novel mechanism of action as a respiratory stimulant.

Metagenomi, a gene editing company with a versatile portfolio of next-generation CRISPR gene editing tools, today announced its participation in the following investor and industry conferences.

ScaleReady Introduces the Cue ® Cell Processing System From Fresenius Kabi.

OpGen, Inc. today announced its successful completion of patient enrollment for its clinical trial for the Unyvero Urinary Tract Infection (UTI) Panel.

IntegriChain announced that two of its Contracts & Pricing experts will speak at the Medicaid Drug Rebate Program Summit, being held as a hybrid event October 12 to 14 in Chicago.

Incyte announced that the Company has entered into an agreement to acquire Villaris Therapeutics, an asset-centric biopharmaceutical company seeded by Medicxi and focused on the development of novel antibody therapeutics for vitiligo.

Modular Medical Inc., a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, provided an update on its insulin pump product.

Eligo Bioscience announced the issuance by the US Patent and Trademark Office of an additional landmark patent that further strengthens Eligo’s dominant position in the field of CRISPR-based killing of bacteria.